Xavier Thomas
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 2
- Hematopoietic Stem Cell Transplantation 1
-
- Acute Lymphoblastic Leukemia research 4
- Co-authors
- Christian Récher (2 shared papers)Claude Preudhomme (2 shared papers)Céline Berthon (2 shared papers)Christophe Roumier (1 shared paper)Norbert Vey (1 shared paper)Carmen Kahatt (1 shared paper)Patrice Herait (1 shared paper)Karen Yee (1 shared paper)
- Journals
- Journal of Medical Economics (1 paper)Blood Advances (1 paper)The Lancet Haematology (1 paper)American Journal of Hematology (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Xavier Thomas
7 papers receiving 422 citations
Xavier Thomas's Hit Papers
Peers
Comparison fields: 5 of 35
- Hematology 259
- Molecular Biology 333
- Genetics 29
- Oncology 74
- Public Health, Environmental and Occupational Health 77
Countries citing papers authored by Xavier Thomas
This map shows the geographic impact of Xavier Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Thomas more than expected).
Fields of papers citing papers by Xavier Thomas
This network shows the impact of papers produced by Xavier Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Thomas. The network helps show where Xavier Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study Hit paper breakdown → | 2016 | 336 |
| 2 | 2001 | 57 | |
| 3 | 2021 | 17 | |
| 4 | 2016 | 7 | |
| 5 | 2016 | 6 | |
| 6 | 2016 | 5 | |
| 7 | 2020 | 2 |
About Xavier Thomas
Xavier Thomas is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Genetics, having authored 7 papers that have together received 430 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Multiple Myeloma Research and Treatments (2 papers), Neutropenia and Cancer Infections (2 papers), Epigenetics and DNA Methylation (1 paper), Protein Degradation and Inhibitors (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (259 citations), Molecular Biology (333 citations), Genetics (29 citations), Oncology (74 citations) and Public Health, Environmental and Occupational Health (77 citations). Xavier Thomas has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Christian Récher, Claude Preudhomme, Céline Berthon, Christophe Roumier, Norbert Vey, Carmen Kahatt, Patrice Herait, Karen Yee, Keyvan Rezaï and Carlos Gomez‐Roca. Their work appears in journals such as Journal of Medical Economics, Blood Advances, The Lancet Haematology, American Journal of Hematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.